Spain · AEMPS CIMA
BEXSERO SUSPENSION INYECTABLE EN JERINGA PRECARGADA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 112812001
- Form
- SUSPENSIÓN INYECTABLE
- Composition / generic term
- vacuna anti meningococo B
- Source strength
- 0,5 ml dosis única
- Authorisation holder
- Glaxosmithkline Vaccines S.R.L.
- Marketed in source snapshot
- Yes
Source-listed ingredients
- PROTEINA RECOMBINANTE DE FUSION NHBA DE NEISSERIA MENINGITIDIS DEL GRUPO B — 50 µg
- PROTEINA RECOMBINANTE NADA DE NEISSERIA MENINGITIDIS DEL GRUPO B — 50 µg
- PROTEINA RECOMBINANTE DE FUSION FHBP DE NEISSERIA MENINGITIDIS DEL GRUPO B — 50 µg
- VESICULAS DE LA MEMBRANA EXTERNA (OMV) DE NEISSERIA MENINGITIDIS GRUPO B (CEPA NZ98/254 MEDIDAS COMO LA CANTIDAD TOTAL DE PROTEINA QUE CONTIENE EL PORA P1.4) — 25 µg
These values do not establish equivalence or a dose recommendation.
Packages
- BEXSERO SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada con aguja
Source and coverage
- Professional information (original source)
- Patient leaflet (original source)
- Official document (original source)
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →